310 results
8-K
EX-10.3
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.2
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.4
NAVB
Navidea Biopharmaceuticals, Inc.
1 Dec 23
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
11:49am
8-K
EX-10.1
NAVB
Navidea Biopharmaceuticals, Inc.
16 Nov 23
Entry into a Material Definitive Agreement
4:55pm
8-K
EX-10.1
63d187y6keyp4 9oxh3e
28 Jul 23
Departure of Directors or Certain Officers
5:10pm
8-K
EX-10.1
c4ocdd
6 Jul 23
Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
4:39pm
8-K
EX-10.1
jr0e3ibx4 gt8nukat
16 Jun 23
Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
5:24pm
8-K
EX-10.1
ouno780vf78j21jd5kbm
2 Jun 23
Entry into a Material Definitive Agreement
6:14pm
8-K
EX-10.2
hv9u91d0h4uig72iamj
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
4j3khuzvboyo
25 May 23
Entry into a Material Definitive Agreement
4:14pm
8-K
EX-10.1
sz598p
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.2
oplqsf
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.4
s3f7pk2
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.3
yb76be
28 Apr 23
Navidea Biopharmaceuticals, Inc. Announces Intent to sell Cardinal Milestone Payment for $8 Million; Secures New $2.75 Million Equity Line of Credit
10:56am
8-K
EX-10.1
32kt6hc8xhfpb
13 Apr 23
Navidea Biopharmaceuticals, Inc. Enters Asset Purchase Agreement with Meilleur Technologies, Inc. for Rights to NAV4694
5:24pm
8-K
EX-10.1
f41c7ca
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
8-K
EX-10.2
iie wshgldzw6ixeo
31 Mar 23
Departure of Directors or Certain Officers
5:20pm
S-8
EX-10.1
duq1632t0pbmsn5p4e
22 Dec 22
Registration of securities for employees
4:19pm
8-K
EX-10.1
o3bgsz8d zb
12 Apr 22
Navidea Biopharmaceuticals Receives Acceptance Letter from NYSE American
4:11pm